Portfolio company
PRINTYMED
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company produces biomimetic spider silk materials for medical researchers, healthcare providers, and cosmetic manufacturers to enable regenerative treatments and sustainable product formulations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Silk Biomaterials
This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.
Brinter
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
Sofregen
This company develops silk protein biomaterials for medical practitioners to facilitate soft tissue regeneration in surgical and aesthetic procedures.
GeniPhys
This company develops polymerisable collagen scaffolds for tissue restoration and wound management for medical patients and healthcare providers.
VIVOLTA
This company develops and manufactures electrospun medical products, such as implants and drug delivery solutions, for medical device and pharmaceutical companies.
BioSapien
This company develops 3D-printed biodegradable mesh for localized and sustained delivery of chemotherapy drugs to cancer patients.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
Besthealth4u
This company develops bio-based medical adhesives and wearable sensor patches for wound care and medical device manufacturers to prevent skin injuries and monitor healing.
